Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corp. Plc | 23.83% | 20.94 | 1.7% | $162.94m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 1.85% | 27.01 | 14.1% | $158.93m | |
| BHC | Bausch Health Cos., Inc. | 1.85% | 27.01 | 0.0% | $119.66m | |
| GWPH | GW Pharmaceuticals Plc | -3.38% | 109.40 | 6.2% | $81.05m | |
| MDCO | The Medicines Co. | -3.58% | 53.39 | 20.2% | $78.63m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.11% | 132.33 | 2.3% | $69.12m | |
| SAGE | SAGE Therapeutics, Inc. | -1.93% | 141.55 | 8.6% | $52.41m | |
| PRGO | Perrigo Co. Plc | -1.67% | 48.28 | 6.8% | $46.00m | |
| ENDP | Endo International Plc | 0.61% | 4.14 | 8.8% | $44.46m | |
| HZNP | Horizon Therapeutics Plc | 0.73% | 30.23 | 6.6% | $40.27m | |
| UTHR | United Therapeutics Corp. | -1.53% | 89.57 | 14.3% | $39.81m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.29% | 83.02 | 16.9% | $39.56m | |
| ICLR | ICON plc | 0.73% | 147.24 | 4.1% | $37.50m | |
| CTLT | Catalent, Inc. | -0.74% | 49.48 | 2.4% | $32.17m | |
| AERI | Aerie Pharmaceuticals, Inc. | -0.89% | 18.88 | 6.8% | $26.95m |
Company Profile
Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.